Isomerase Therapeutics
Pre-clinicalDevelops novel small molecule therapeutics using biocatalysis and enzyme engineering technologies.
Founded
2013
Focus
Small MoleculesDrug Delivery
About
Develops novel small molecule therapeutics using biocatalysis and enzyme engineering technologies.
Funding History
2Total raised: $12.5M
Series A$10MSR OneJun 15, 2018
Seed$2.5MUndisclosedJun 15, 2015
Company Info
TypePrivate
Founded2013
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile